Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Hum Mutat. 2019 Dec 19;41(3):641–654. doi: 10.1002/humu.23960

Table 2.

Genotype-phenotype correlation for visceral myopathy

Group Inheritance Phenotypes Outcomes Observed
ACTG2:p.Arg178 De novo or dominant inherited MMIHS-Most severe neonatal presentation with microcolon High rates of mortality and transplantation
ACTG2:p.Arg257 De novo or dominant inherited MMIHS or CIPO. Typically Severe neonatal presentation usually without microcolon and more variability High rates of mortality and transplantation
ACTG2:p.Arg40 De novo or dominant inherited MMIHS or CIPO. Severity range and more moderate or mild cases than groups above Moderate to high rates of mortality and transplantation
ACTG2:Other Arg De novo or dominant inherited MMIHS or CIPO. Severity range and more moderate or mild cases than groups above Moderate rates of mortality and transplantation
Non-Arg ACTG2 De novo or dominant inherited MMIHS or CIPO. Severity range and more moderate or mild cases than groups above Moderate to high rates of mortality and transplantation
ACTG2-negative Sporadic or ultra-rare recessive Less severe as a group than ACTG2 positive, but some severe cases Low rates of mortality and transplantation

Abbreviations: CIPO, chronic intestinal pseudo-obstruction; MMIHS, megacystis-microcolon intestinal hypoperistalsis syndrome